Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating boceprevir added to standard of care in previously treated chronic hepatitis C genotype 1 with cirrhosis; completed with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2016-11-21